Developer docs
API playgroundTry for free, no card

Search company profiles

Capital Pathology

Full company profile

uuid002zbka

Namestring
Capital Pathology
Legal namestring
Capital Pathology
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Capital Pathology is a diagnostic pathology laboratory headquartered in Deakin, ACT, Australia, providing comprehensive testing services to medical practitioners (GPs and specialists), private hospitals, and aged care facilities across the ACT and regional New South Wales (Southern Tablelands, Snowy Mountains, and South Coast NSW). Its main Deakin laboratory operates 24 hours and holds Category GX NATA/RCPA accreditation (the highest classification), supported by regional laboratories in Bega and Goulburn and a network of over 40 collection centres. Core testing spans haematology, biochemistry, immunology, microbiology, anatomical pathology, and cytology, alongside specialised services including cervical (HPV) screening, familial hypercholesterolaemia (FH) genetic testing, STI testing, cardiac services (ECG, Holter), blood bank/transfusion, and commercial/occupational testing. The company is a subsidiary of Sonic Healthcare Limited, Australia's largest pathology group and one of the largest globally, operating under Sonic's federated model with local autonomy.

Technically, the company differentiates through electronic ordering (eOrdering) integrated with Best Practice and Medical Director practice management software, enabling clinicians to generate referrals during consultations; patients receive an SMS barcode within two minutes for scanning at collection centres, including a telehealth-triggered variant. Clinician-facing reporting and workflow tools include Sonic Dx, Webster, and Fetch, complemented by online audit and education tools (HPV Audit, Skin Cancer Audit, CST Audit, Sonic Education). Specialised genetic and DNA testing is delivered via Sonic Genetics (NIPT, reproductive carrier screening) and DNALabs (parentage/relationship testing), cross-referenced within the Sonic network.

The business model is sales-led (referrals from clinicians and institutional clients via a Doctor Service Centre and Client Services team) combined with direct-to-consumer access through collection centres, home visits, and the MyTest results portal. Revenue is transaction-based across several streams: Medicare-rebatable outpatient testing (with a $50 gap cap and bulk billing for concession holders, children under 16, and DVA patients), private/AMA-rate billing for non-Medicare and international patients, no-gap direct billing to health funds, self-funded immunity/infection screening (e.g., Hepatitis B $50, QuantiFERON Gold $75, individual immunity tests $25 each), negotiated corporate/commercial testing, and specialised genetic testing.

Short descriptiontext

Capital Pathology is a Sonic Healthcare–owned diagnostic pathology laboratory in Deakin, ACT, serving GPs, specialists, private hospitals, aged care facilities, and corporate clients across the ACT and regional NSW through a network of 40-plus collection centres.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersDeakin, Australia
HQ citystring
Deakin
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
diagnostic pathology services, blood testing laboratory, medical collection centres, genetic screening services, workplace health screening
Industry2 codes
PRIMARYHLAFAMAA
Anatomic Pathology (Histopathology & Cytopathology)
SECONDARYHLAAALAI
Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays)
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Diagnostic Pathology Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Medicare Rebateable Pathology Testing
TypeSubscription Recurring
Description

Capital Pathology bulk bills concession card holders, children under 16, and DVA patients. For other Medicare patients, out-of-pocket costs are capped at $50. Most standard pathology tests are covered under the Medicare Benefits Schedule (MBS). Revenue is derived from Medicare rebates paid per test.

capitalpath.com.au
2Private Patient Billing
TypeTransaction Fee
Description

Patients without Medicare (overseas visitors, students) are billed at AMA (Australian Medical Association) rates. Patients with health insurance may claim rebates per their insurer coverage. No-gap agreements with major health funds result in direct billing to the fund with no patient out-of-pocket costs.

capitalpath.com.au
3Self-Funded Non-Medicare Pathology
TypeTransaction Fee
Description

Immunity and infection screening for healthcare employment and clinical placement is self-funded by patients. Tests include Hepatitis B ($50), QuantiFERON Gold for TB ($75), and individual immunity tests ($25 each for Measles, Mumps, Rubella, Varicella). Medicare does not cover these administrative-requirement tests.

capitalpath.com.au
4Corporate / Commercial Pathology Services
TypeTransaction Fee
Description

Workplace drug and alcohol testing, pre-employment screening, hazardous materials monitoring (heavy metals, PFAS, Q-fever, TB), COVID-19 workplace screening, and corporate health and wellness programs for corporate clients. Fees are negotiated per engagement.

capitalpath.com.au
5Specialised Genetic Testing
TypeTransaction Fee
Description

Specialised services including NIPT (via Sonic Genetics), DNALabs parentage and relationship testing, and FH genetic testing. Some genetic tests are Medicare rebatable (e.g., reproductive carrier screening), while others are privately billed.

capitalpath.com.au
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Pricing details4 tiers
1Medicare Rebatable Outpatient Testing
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Maximum gap of $50 for patients with Medicare for tests covered under the Medicare Benefits Schedule.

capitalpath.com.au
2Non-Medicare (International/Overseas) Patients
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Billed at AMA (Australian Medical Association) rates. Payment required at time of collection. Direct billing available for OSHC Allianz and Medibank Private insured international students.

capitalpath.com.au
3Healthcare Employment Immunity Screening (Self-Funded)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Measles IgG $25, Mumps IgG $25, Rubella IgG $25, Varicella IgG $25, Hepatitis B $50, QuantiFERON Gold (TB) $75. Not covered by Medicare.

capitalpath.com.au
4Inpatient No-Gap Health Funds
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Patients with private health funds that have a no-gap agreement with Capital Pathology are billed directly with no out-of-pocket costs.

capitalpath.com.au
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Capital Pathology operates a 24-hour diagnostic pathology laboratory in Deakin, ACT, providing comprehensive testing across haematology, biochemistry, immunology, microbiology, anatomical pathology, and cytology. Services are delivered through a network of over 40 collection centres, regional laboratories in Bega and Goulburn, and a courier specimen transport network, serving referring GPs, specialists, private hospitals, aged care facilities, corporate clients, and individual patients across the ACT and regional NSW. The offering includes specialised sub-brands for genetic testing (Sonic Genetics, DNALabs), familial hypercholesterolaemia screening, cervical screening, cardiac services, and workplace health programs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Results available within 24 hours for routine tests
+1 more record
Product overview1 text field

Capital Pathology operates as a comprehensive pathology service provider offering a unified diagnostic platform centered on laboratory testing services. The core offering consists of 24-hour pathology testing across multiple disciplines (haematology, biochemistry, immunology, microbiology, anatomical pathology, cytology) delivered through a network of over 40 collection centres with courier specimen transport. The service portfolio extends through specialized sub-brands including Sonic Genetics for NIPT and reproductive genetic testing, and DNALabs for parentage/relationship DNA testing. Additional modules include electronic ordering (eOrdering) for Best Practice/Medical Director practices, clinical reporting tools (Sonic Dx, Webster, Fetch), cardiac monitoring services (ECG, Holter), corporate/commercial testing services, and immunity screening programs. The company is part of Sonic Healthcare and maintains NATA/ISO 15189 accreditation.

Product and service12 records
1Pathology Testing Services
CategoryCore Pathology Laboratory Services
Description

Core 24-hour pathology laboratory testing services including haematology, biochemistry, immunology, microbiology, anatomical pathology, and cytology, serving referring GPs, specialists, hospitals, and patients across the ACT and regional NSW.

2Collection Centre Network
CategoryPatient Access and Sample Collection
Description

Network of over 40 collection centres across Canberra and regional NSW (including Southern Tablelands, Snowy Mountains, and South Coast NSW) offering blood collection services, with early morning and weekend hours, online and walk-in appointments, and home visit phlebotomy for eligible patients.

3Courier Specimen Transport Services
CategoryLogistics and Specimen Transport
Description

Specimen transport services with regular multiple daily pickups from hospitals, nursing homes, doctors' practices, and collection centres, plus 24/7 urgent specimen transport from selected hospitals.

4Blood Bank and Transfusion Services
CategoryClinical Pathology Services
Description

Blood bank services including blood typing, Rh factor testing, antibody screening, and transfusion support for hospital patients.

5Cervical Screening Testing
CategorySpecialised Screening Services
Description

HPV-based cervical cancer screening performed every five years for women aged 25-74, detecting high-risk HPV types 16 and 18.

6Cardiac Services
CategorySpecialist Diagnostic Services
Description

ECG recording and interpretation by specialist cardiologists, and Holter monitor service with specialist cardiology reporting.

7Commercial and Corporate Testing Services
CategoryOccupational and Corporate Health Services
Description

Corporate and workplace testing services including hazardous materials monitoring (heavy metals, herbicides, PFOS/PFAS), drug and alcohol testing, pre-employment screening, and COVID-19 workplace screening with 12-24 hour result turnaround.

8Familial Hypercholesterolaemia (FH) Genetic Testing
CategorySpecialised Genetic Testing Services
Description

Open-access genetic testing for familial hypercholesterolaemia diagnosis, connecting patients with FH specialists via telehealth for diagnostic assessment, informed consent, and cascade family testing.

9DNALabs Parentage and Relationship Testing
CategorySpecialised DNA Testing Services
Description

DNA-based parentage (paternity) and relationship testing for legal, immigration, and peace-of-mind purposes, NATA-accredited to ISO/IEC 17025.

10Sonic Genetics NIPT and Genetic Testing
CategorySpecialised Genetic Testing Services
Description

Non-Invasive Prenatal Testing (NIPT) — a DNA-based blood test measuring the chance of common genetic conditions from as early as 10 weeks' gestation, plus reproductive carrier screening, cancer genetics, and pharmacogenomics.

11Immunity and Infection Screening
CategoryOccupational Health and Pre-Employment Screening
Description

Self-funded testing program for healthcare employment and student clinical placement, including measles, mumps, rubella, varicella, hepatitis B, and tuberculosis (QuantiFERON Gold) screening to meet mandatory health requirements.

12STI Testing
CategoryPatient Diagnostic Services
Description

Sexually transmitted infection testing services with options for GP referral, sexual health clinic access, or online ordering via SmartHealth platform.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Sonic Healthcare Limited is the parent company of Capital Pathology. Sonic Healthcare is Australia's largest pathology provider and one of the largest in the world, operating across Australasia, Europe, and North America with over 2,200 pathologists and approximately 18,000 employees. Capital Pathology operates as part of Sonic's federated model, maintaining local autonomy while benefiting from the group's scale, resources, and international network.

Strategic tierCoreTypeTechnology or Integration
Description

Capital Pathology's electronic ordering (eOrdering) system is integrated with Best Practice and Medical Director practice management software. Clinicians using Best Practice can generate electronic pathology referrals during consultations, triggering SMS delivery of barcodes to patients.

Strategic tierCoreTypeTechnology or Integration
Description

Capital Pathology's electronic ordering (eOrdering) system is integrated with Medical Director practice management software. Clinicians using Medical Director can generate electronic pathology referrals during consultations, triggering SMS delivery of barcodes to patients for scanning at collection centres.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Sonic Genetics is the genetic testing division of Sonic Healthcare, offering NIPT, reproductive carrier screening, cancer genetics, pharmacogenomics, and other genetic tests. Capital Pathology refers patients for these specialised genetic services, providing integrated access to genetic testing within the Sonic network.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

DNALabs is the parentage and relationship DNA testing service within Sonic Healthcare. Capital Pathology offers DNALabs parentage and relationship testing through its specialised services. DNALabs has a nationwide collection centre network and NATA-accredited laboratory in Sydney.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Capital Pathology is part of the wider Sonic Commercial Pathology network, providing corporate and occupational health testing services including drug and alcohol testing, pre-employment screening, and hazardous materials monitoring. The commercial network provides operational expertise for workplace health programs.

7ACT Pathology
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Several Capital Pathology pathologists have trained at or collaborated with ACT Pathology (Canberra Hospital). Dr Ingrid Fewings completed part of her anatomical pathology training at ACT Pathology, and Dr Divya Srivastava completed required training from both Capital Pathology and ACT Pathology before receiving her RCPA fellowship.

capitalpath.com.au
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Sonic Healthcare pathology subsidiary serving Sydney and regional NSW with a full anatomic/clinical pathology menu and integrated electronic ordering. Direct peer in scale, scope and Sonic operating model, with overlapping regional NSW catchment to Capital Pathology's southern service area.

TypeDirect peer
Description

ASX-listed national pathology operator (ACL) with collection-centre networks, anatomic/clinical pathology and corporate/occupational testing. Closest non-Sonic direct peer, comparable in scale of collection network and breadth of services.

TypeDirect peer
Description

Sonic Healthcare pathology subsidiary operating across NSW and ACT with collection centres, electronic ordering and a comparable Medicare/private payer mix. Direct peer in service offering and in overlapping ACT/NSW geography.

4ACT Pathology
TypeDirect peer
Description

Public pathology service for Canberra Hospital and ACT Health. Operates in the same ACT geography as Capital Pathology, serves many of the same referring clinicians (and is a documented training partner for several Capital Pathology pathologists), and competes for hospital and GP referrals.

TypeBroad incumbent
Description

Public-sector pathology provider operating across NSW public hospitals and some community collection. Comparable in clinical and anatomic pathology menu and overlapping regional NSW geography, but a public-sector incumbent with a different funding model.

TypeOthers
Description

NATA-accredited (ISO/IEC 17025) parentage and relationship DNA testing service within Sonic Healthcare, offered through Capital Pathology's collection centres. Sister entity that monetises a specialised service line Capital Pathology hosts but does not directly perform.

TypeDirect peer
Description

Fellow Sonic Healthcare pathology subsidiary operating a 24-hour central laboratory and large collection-centre network across Queensland and northern NSW. Closest direct peer given shared Sonic operating model, similar collection-centre-led GTM and Medicare-rebate-driven revenue mix.

TypeEmerging player
Description

Privately held Australian pathology operator that has rapidly expanded a bulk-billed collection-centre network across multiple states. Comparable in collection-centre-led outpatient model and Medicare-bulk-bill positioning, and an emerging competitive threat in regional catchments.

TypeBroad incumbent
Description

Parent of QML, Dorevitch, Western Diagnostic Pathology and other brands; one of Australia's largest pathology operators. Comparable in core diagnostic pathology offering but broader, multi-brand incumbent rather than a regional specialist.

TypeOthers
Description

Genetic testing division of Sonic Healthcare, accessed by Capital Pathology patients for NIPT, reproductive carrier screening and other specialised assays. Sister entity rather than competitor, but a key channel partner for Capital Pathology's higher-value genetic revenue.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Capital Pathology

Diagnostic Pathology Servicescapitalpath.com.au

Capital Pathology is a Sonic Healthcare–owned diagnostic pathology laboratory in Deakin, ACT, serving GPs, specialists, private hospitals, aged care facilities, and corporate clients across the ACT and regional NSW through a network of 40-plus collection centres.

What Capital Pathology does

Capital Pathology is a diagnostic pathology laboratory headquartered in Deakin, ACT, Australia, providing comprehensive testing services to medical practitioners (GPs and specialists), private hospitals, and aged care facilities across the ACT and regional New South Wales (Southern Tablelands, Snowy Mountains, and South Coast NSW). Its main Deakin laboratory operates 24 hours and holds Category GX NATA/RCPA accreditation (the highest classification), supported by regional laboratories in Bega and Goulburn and a network of over 40 collection centres. Core testing spans haematology, biochemistry, immunology, microbiology, anatomical pathology, and cytology, alongside specialised services including cervical (HPV) screening, familial hypercholesterolaemia (FH) genetic testing, STI testing, cardiac services (ECG, Holter), blood bank/transfusion, and commercial/occupational testing. The company is a subsidiary of Sonic Healthcare Limited, Australia's largest pathology group and one of the largest globally, operating under Sonic's federated model with local autonomy.

Technically, the company differentiates through electronic ordering (eOrdering) integrated with Best Practice and Medical Director practice management software, enabling clinicians to generate referrals during consultations; patients receive an SMS barcode within two minutes for scanning at collection centres, including a telehealth-triggered variant. Clinician-facing reporting and workflow tools include Sonic Dx, Webster, and Fetch, complemented by online audit and education tools (HPV Audit, Skin Cancer Audit, CST Audit, Sonic Education). Specialised genetic and DNA testing is delivered via Sonic Genetics (NIPT, reproductive carrier screening) and DNALabs (parentage/relationship testing), cross-referenced within the Sonic network.

The business model is sales-led (referrals from clinicians and institutional clients via a Doctor Service Centre and Client Services team) combined with direct-to-consumer access through collection centres, home visits, and the MyTest results portal. Revenue is transaction-based across several streams: Medicare-rebatable outpatient testing (with a $50 gap cap and bulk billing for concession holders, children under 16, and DVA patients), private/AMA-rate billing for non-Medicare and international patients, no-gap direct billing to health funds, self-funded immunity/infection screening (e.g., Hepatitis B $50, QuantiFERON Gold $75, individual immunity tests $25 each), negotiated corporate/commercial testing, and specialised genetic testing.

Capital Pathology firmographics

Firmographics
Name
Capital Pathology
Legal name
Capital Pathology
Website
https://capitalpath.com.au
Company type
Private
Operating status
Operating
Headcount range
51–100 employees
Short description
Capital Pathology is a Sonic Healthcare–owned diagnostic pathology laboratory in Deakin, ACT, serving GPs, specialists, private hospitals, aged care facilities, and corporate clients across the ACT and regional NSW through a network of 40-plus collection centres.
Ownership category
akta.pro rank

Capital Pathology industry classification

Industry
Product category
Diagnostic Pathology Services
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAFAMAA
Anatomic Pathology (Histopathology & Cytopathology)
SECONDARYHLAAALAI
Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays)

Keywords

  • Diagnostic pathology services
  • Blood testing laboratory
  • Medical collection centres
  • Genetic screening services
  • Workplace health screening

Where Capital Pathology is headquartered

Location

Headquarters

HQ city
Deakin
HQ country
Australia
HQ region
Oceania

Offices4 records

Markets served

Capital Pathology business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Medicare Rebateable Pathology Testing: Capital Pathology bulk bills concession card holders, children under 16, and DVA patients. For other Medicare patients, out-of-pocket costs are capped at $50. Most standard pathology tests are covered under the Medicare Benefits Schedule (MBS). Revenue is derived from Medicare rebates paid per test.
  2. Private Patient Billing: Patients without Medicare (overseas visitors, students) are billed at AMA (Australian Medical Association) rates. Patients with health insurance may claim rebates per their insurer coverage. No-gap agreements with major health funds result in direct billing to the fund with no patient out-of-pocket costs.
  3. Self-Funded Non-Medicare Pathology: Immunity and infection screening for healthcare employment and clinical placement is self-funded by patients. Tests include Hepatitis B ($50), QuantiFERON Gold for TB ($75), and individual immunity tests ($25 each for Measles, Mumps, Rubella, Varicella). Medicare does not cover these administrative-requirement tests.
  4. Corporate / Commercial Pathology Services: Workplace drug and alcohol testing, pre-employment screening, hazardous materials monitoring (heavy metals, PFAS, Q-fever, TB), COVID-19 workplace screening, and corporate health and wellness programs for corporate clients. Fees are negotiated per engagement.
  5. Specialised Genetic Testing: Specialised services including NIPT (via Sonic Genetics), DNALabs parentage and relationship testing, and FH genetic testing. Some genetic tests are Medicare rebatable (e.g., reproductive carrier screening), while others are privately billed.

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goMedicare Rebatable Outpatient Testing
Transaction based/ take ratePay-as-you-goNon-Medicare (International/Overseas) Patients
Unit PricingPay-as-you-goHealthcare Employment Immunity Screening (Self-Funded)
Transaction based/ take ratePay-as-you-goInpatient No-Gap Health Funds

Go-to-market motion2 records

Distribution channels6 records

Marketing channels7 records

Capital Pathology product offering

Product offering

Core offering

Capital Pathology operates a 24-hour diagnostic pathology laboratory in Deakin, ACT, providing comprehensive testing across haematology, biochemistry, immunology, microbiology, anatomical pathology, and cytology. Services are delivered through a network of over 40 collection centres, regional laboratories in Bega and Goulburn, and a courier specimen transport network, serving referring GPs, specialists, private hospitals, aged care facilities, corporate clients, and individual patients across the ACT and regional NSW. The offering includes specialised sub-brands for genetic testing (Sonic Genetics, DNALabs), familial hypercholesterolaemia screening, cervical screening, cardiac services, and workplace health programs.

Product overview

Capital Pathology operates as a comprehensive pathology service provider offering a unified diagnostic platform centered on laboratory testing services. The core offering consists of 24-hour pathology testing across multiple disciplines (haematology, biochemistry, immunology, microbiology, anatomical pathology, cytology) delivered through a network of over 40 collection centres with courier specimen transport. The service portfolio extends through specialized sub-brands including Sonic Genetics for NIPT and reproductive genetic testing, and DNALabs for parentage/relationship DNA testing. Additional modules include electronic ordering (eOrdering) for Best Practice/Medical Director practices, clinical reporting tools (Sonic Dx, Webster, Fetch), cardiac monitoring services (ECG, Holter), corporate/commercial testing services, and immunity screening programs. The company is part of Sonic Healthcare and maintains NATA/ISO 15189 accreditation.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pathology Testing Services Core 24-hour pathology laboratory testing services including haematology, biochemistry, immunology, microbiology, anatomical pathology, and cytology, serving referring GPs, specialists, hospitals, and patients across the ACT and regional NSW.
  • Collection Centre Network Network of over 40 collection centres across Canberra and regional NSW (including Southern Tablelands, Snowy Mountains, and South Coast NSW) offering blood collection services, with early morning and weekend hours, online and walk-in appointments, and home visit phlebotomy for eligible patients.
  • Courier Specimen Transport Services Specimen transport services with regular multiple daily pickups from hospitals, nursing homes, doctors' practices, and collection centres, plus 24/7 urgent specimen transport from selected hospitals.
  • Blood Bank and Transfusion Services Blood bank services including blood typing, Rh factor testing, antibody screening, and transfusion support for hospital patients.
  • Cervical Screening Testing HPV-based cervical cancer screening performed every five years for women aged 25-74, detecting high-risk HPV types 16 and 18.
  • Cardiac Services ECG recording and interpretation by specialist cardiologists, and Holter monitor service with specialist cardiology reporting.
  • Commercial and Corporate Testing Services Corporate and workplace testing services including hazardous materials monitoring (heavy metals, herbicides, PFOS/PFAS), drug and alcohol testing, pre-employment screening, and COVID-19 workplace screening with 12-24 hour result turnaround.
  • Familial Hypercholesterolaemia (FH) Genetic Testing Open-access genetic testing for familial hypercholesterolaemia diagnosis, connecting patients with FH specialists via telehealth for diagnostic assessment, informed consent, and cascade family testing.
  • DNALabs Parentage and Relationship Testing DNA-based parentage (paternity) and relationship testing for legal, immigration, and peace-of-mind purposes, NATA-accredited to ISO/IEC 17025.
  • Sonic Genetics NIPT and Genetic Testing Non-Invasive Prenatal Testing (NIPT) — a DNA-based blood test measuring the chance of common genetic conditions from as early as 10 weeks' gestation, plus reproductive carrier screening, cancer genetics, and pharmacogenomics.
  • Immunity and Infection Screening Self-funded testing program for healthcare employment and student clinical placement, including measles, mumps, rubella, varicella, hepatitis B, and tuberculosis (QuantiFERON Gold) screening to meet mandatory health requirements.
  • STI Testing Sexually transmitted infection testing services with options for GP referral, sexual health clinic access, or online ordering via SmartHealth platform.

Quantifiable outcome

  • Results available within 24 hours for routine tests
  • +1 more outcomes

Companies that use Capital Pathology

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Capital Pathology technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature3 records

Capital Pathology partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered flagship, core and minor.

  • Sonic Healthcare LimitedflagshipStrategic or Co-development PartnerSonic Healthcare Limited is the parent company of Capital Pathology. Sonic Healthcare is Australia's largest pathology provider and one of the largest in the world, operating across Australasia, Europe, and North America with over 2,200 pathologists and approximately 18,000 employees. Capital Pathology operates as part of Sonic's federated model, maintaining local autonomy while benefiting from the group's scale, resources, and international network.
  • Best Practice SoftwarecoreTechnology or IntegrationCapital Pathology's electronic ordering (eOrdering) system is integrated with Best Practice and Medical Director practice management software. Clinicians using Best Practice can generate electronic pathology referrals during consultations, triggering SMS delivery of barcodes to patients.
  • Medical Director (Software)coreTechnology or IntegrationCapital Pathology's electronic ordering (eOrdering) system is integrated with Medical Director practice management software. Clinicians using Medical Director can generate electronic pathology referrals during consultations, triggering SMS delivery of barcodes to patients for scanning at collection centres.
  • Sonic GeneticscoreStrategic or Co-development PartnerSonic Genetics is the genetic testing division of Sonic Healthcare, offering NIPT, reproductive carrier screening, cancer genetics, pharmacogenomics, and other genetic tests. Capital Pathology refers patients for these specialised genetic services, providing integrated access to genetic testing within the Sonic network.
  • DNALabscoreStrategic or Co-development PartnerDNALabs is the parentage and relationship DNA testing service within Sonic Healthcare. Capital Pathology offers DNALabs parentage and relationship testing through its specialised services. DNALabs has a nationwide collection centre network and NATA-accredited laboratory in Sydney.
  • Sonic Commercial PathologycoreStrategic or Co-development PartnerCapital Pathology is part of the wider Sonic Commercial Pathology network, providing corporate and occupational health testing services including drug and alcohol testing, pre-employment screening, and hazardous materials monitoring. The commercial network provides operational expertise for workplace health programs.
  • ACT PathologyminorStrategic or Co-development PartnerSeveral Capital Pathology pathologists have trained at or collaborated with ACT Pathology (Canberra Hospital). Dr Ingrid Fewings completed part of her anatomical pathology training at ACT Pathology, and Dr Divya Srivastava completed required training from both Capital Pathology and ACT Pathology before receiving her RCPA fellowship.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Capital Pathology competitors and assessment

Company assessment

Direct peers

  • Douglass Hanly Moir Pathology: Sonic Healthcare pathology subsidiary serving Sydney and regional NSW with a full anatomic/clinical pathology menu and integrated electronic ordering. Direct peer in scale, scope and Sonic operating model, with overlapping regional NSW catchment to Capital Pathology's southern service area.
  • Australian Clinical Labs: ASX-listed national pathology operator (ACL) with collection-centre networks, anatomic/clinical pathology and corporate/occupational testing. Closest non-Sonic direct peer, comparable in scale of collection network and breadth of services.
  • Laverty Pathology: Sonic Healthcare pathology subsidiary operating across NSW and ACT with collection centres, electronic ordering and a comparable Medicare/private payer mix. Direct peer in service offering and in overlapping ACT/NSW geography.
  • ACT Pathology: Public pathology service for Canberra Hospital and ACT Health. Operates in the same ACT geography as Capital Pathology, serves many of the same referring clinicians (and is a documented training partner for several Capital Pathology pathologists), and competes for hospital and GP referrals.
  • Sullivan Nicolaides Pathology: Fellow Sonic Healthcare pathology subsidiary operating a 24-hour central laboratory and large collection-centre network across Queensland and northern NSW. Closest direct peer given shared Sonic operating model, similar collection-centre-led GTM and Medicare-rebate-driven revenue mix.

Broad incumbents

  • NSW Health Pathology: Public-sector pathology provider operating across NSW public hospitals and some community collection. Comparable in clinical and anatomic pathology menu and overlapping regional NSW geography, but a public-sector incumbent with a different funding model.
  • Healius Pathology: Parent of QML, Dorevitch, Western Diagnostic Pathology and other brands; one of Australia's largest pathology operators. Comparable in core diagnostic pathology offering but broader, multi-brand incumbent rather than a regional specialist.

Others

  • DNALabs: NATA-accredited (ISO/IEC 17025) parentage and relationship DNA testing service within Sonic Healthcare, offered through Capital Pathology's collection centres. Sister entity that monetises a specialised service line Capital Pathology hosts but does not directly perform.
  • Sonic Genetics: Genetic testing division of Sonic Healthcare, accessed by Capital Pathology patients for NIPT, reproductive carrier screening and other specialised assays. Sister entity rather than competitor, but a key channel partner for Capital Pathology's higher-value genetic revenue.

Emerging players

  • 4Cyte Pathology: Privately held Australian pathology operator that has rapidly expanded a bulk-billed collection-centre network across multiple states. Comparable in collection-centre-led outpatient model and Medicare-bulk-bill positioning, and an emerging competitive threat in regional catchments.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Capital Pathology social profiles

Digital presence

Capital Pathology compliance and trust

Trust signal

Compliance4 records

Capital Pathology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Capital Pathology leadership team

Management profile

Number of profiles

Profiles10 records

Capital Pathology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Capital Pathology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Capital Pathology

What does Capital Pathology do?

Capital Pathology operates a 24-hour diagnostic pathology laboratory in Deakin, ACT, providing comprehensive testing across haematology, biochemistry, immunology, microbiology, anatomical pathology, and cytology. Services are delivered through a network of over 40 collection centres, regional laboratories in Bega and Goulburn, and a courier specimen transport network, serving referring GPs, specialists, private hospitals, aged care facilities, corporate clients, and individual patients across the ACT and regional NSW. The offering includes specialised sub-brands for genetic testing (Sonic Genetics, DNALabs), familial hypercholesterolaemia screening, cervical screening, cardiac services, and workplace health programs.

Is Capital Pathology a public or private company?

Capital Pathology is a private company. It is classified as corporate owned and is currently operating.

When was Capital Pathology founded?

Capital Pathology was founded in -1. It employs 51 to 100 people.

Where is Capital Pathology based?

Capital Pathology is headquartered in Deakin, Australia, in the Oceania region.

How does Capital Pathology make money?

Five revenue lines are on record. Medicare Rebateable Pathology Testing is the primary driver. The others are private Patient Billing, self-Funded Non-Medicare Pathology, corporate / Commercial Pathology Services and specialised Genetic Testing.

Who are Capital Pathology's main competitors?

Direct peers on record are Douglass Hanly Moir Pathology, Australian Clinical Labs, Laverty Pathology, ACT Pathology and Sullivan Nicolaides Pathology. Broad incumbents are NSW Health Pathology and Healius Pathology. Others are DNALabs and Sonic Genetics. 4Cyte Pathology is listed as an emerging player.

Does Capital Pathology have an API?

No public API is recorded for Capital Pathology.

What industry is Capital Pathology in?

Capital Pathology's product category is Diagnostic Pathology Services. Its primary akta.pro industry code is HLAFAMAA, Anatomic Pathology (Histopathology & Cytopathology), with a secondary code of HLAAALAI, Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales